Orotic acid monohydrate

Orotic acid is a minor dietary constituent. Indeed, until it was realized that it could be synthesized by humans, orotic acid was known as vitamin B-13. The richest dietary sources are cow’s milk and other dairy products as well as root vegetables including carrots and beets. Dietary intake probably contributes to a basal rate of orotic acid excretion in urine because fasting decreases excretion by ~50%. However, it is now apparent that most urinary orotic acid is synthesized in the body, where it arises as an intermediate in the pathway for the synthesis of pyrimidine nucleotides. Orotic acid is converted to UMP by UMP synthase, a multifunctional protein with both orotate phosphoribosyltransferase and orotidylate decarboxylase activity. The most frequently observed inborn error of pyrimidine nucleotide synthesis is a mutation of the multifunctional protein UMP synthase. This disorder prevents the conversion of orotic acid to UMP and thus to other pyrimidines. As a result, plasma orotic acid accumulates to high concentrations, and increased quantities appear in the urine. Indeed, urinary orotic acid is so markedly increased in individuals harboring a mutation in UMP synthase that orotic acid crystals can form in the urine. The urinary concentration of orotic acid in homozygotes can be of the order of millimoles per millimole creatinine. By comparison, the urinary level in unaffected individuals is ~ 1 umol/mmol creatinine. (A3380). The directory classifies it as a commercial API with a biotechnology source/manufacturing origin. Other names for this substance include Lactinium and Oroticum acidum. It is also listed for alternate use as: API Intermediate. Its PubChem CID is 16218504.

CAS No 50887-69-9
Molecular Formula C5H4N2O4.H2O
Molecular Weight 174.11 g/mol
Synonyms 2,4-dioxo-1H-pyrimidine-6-carboxylic acid;hydrate

Frequently Asked Questions